This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Two candidates recently acquired in deals with IAVI and Themis have shown promise in preclinical studies, Merck executives said, and Phase 1 trials will begin later this year.
QUICK READ: A reporter for a leading business magazine recently reached out to me and asked “what are Pharma product websites so bad?” OK, maybe not all of them are that bad but I would bet that 80% are really poor. There is a lot of blame to go around but these facts are still relevant today. 1ne: There is a direct correlation between time on site and asking for/about your product.
Have you ever wondered about the difference between preclinical and nonclinical studies? While those in. The post Preclinical and Nonclinical Studies— What Is the Difference, and Where in Your Program Should They Fall? appeared first on Camargo.
The trial will enrol patients with mild symptoms of SARS-CoV-2 infection to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of CT-P59
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Pharmapack Europe (#pharmapackeu), organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format. The decision follows a careful review with key stakeholders, with the exhibition continuing at its usual location: Hall 7.2 at Paris Expo, Porte de Versailles. By announcing the rescheduling.
Gen Z is setting food trends in the post-pandemic world, The Food Institute reports, and their food choices include: Ordering in more, choosing frozen foods and eating more plant-based meals. They believe you don’t have to be vegan to want to eat more vegan foods, the Institute report noted, in a review of how these young consumers are influencing food trends.
Gen Z is setting food trends in the post-pandemic world, The Food Institute reports, and their food choices include: Ordering in more, choosing frozen foods and eating more plant-based meals. They believe you don’t have to be vegan to want to eat more vegan foods, the Institute report noted, in a review of how these young consumers are influencing food trends.
Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has announced the appointment of Charlie Nicholson as Softbox’s new Global CFO. Reporting directly to Kevin Valentine, CEO of Softbox, Charlie Nicholson joins the leadership team and is responsible for all financial and.
Soil-free, computer-controlled farms could offer a solution for future crop growing as climate change and soil erosion limit farmers’ ability to grow, according to new research. The research , published in New Phytologist and led by scientists at the University of Bristol, John Innes Centre and LettUs Grow, describe the growing environmental and economic case for vertical farming methods which could see crops grown in previously unfarmable environments such as the deserts of Dubai to count
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving “First Patient First Visit[1]” in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of.
For decades, formulation scientists have relied on the assumption that common pharmaceutical excipients are biologically inert. Now, results from a new study conducted by researchers at the UC San Francisco (UCSF) School of Pharmacy and the Novartis Institutes for BioMedical Research (NIBR), have challenged drugmakers’ understanding of the effects of excipients.
Recently, the Healthcare Businesswomen’s Association (HBA) held a webinar entitled, Virtual Best Practices: Clarity, Collaboration and Connecting , which dove into the topic of “Zoom fatigue,” a new, commonly used term defined by the draining feeling you experience after a day of long, unnecessary meetings. We are all facing new challenges in the rapidly changing work environment.
What is a toddler tooth decay? Do you have children in your house? Then you must face the problem of dental cavities and tooth decay and have to deal with these as well. Usually, the decay of the tooth is a breakdown or destruction of tooth enamel. We all know the fact that enamel is. The post How to Know If your Toddler Has Tooth Decay and How to Reverse It?
A study published in Nature on July 30, 2020 states that good bacteria living in our gut can do much more than just help digest food and boost our immune system. According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues. The findings show that the bacteria in the intestine can help repair tissue damage among patients with inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.
The Primary Care Respiratory Society (PCRS) has issued a position statement and recommendations for clinicians on the diagnostic work up of patients presenting with respiratory symptoms while Covid-19 remains in active circulation. The recommendations bring together the cross-functional experience of PCRS members on the safest and most appropriate approach when evaluating patients presenting with respiratory.
Starting next week, Dunkin’ and Bark are collaborating to create a new Dunkin’ inspired plush dog toy being sold in restaurants nationwide. Proceeds are going to the Dunkin’ Joy in Childhood Foundation. The Dunkin’ Joy in Childhood Foundation and Bark are creating dog toys in the shape of Munchkins donut holes and hot coffee cups. The toys will be available at the beginning of August and will be sold in participating restaurants while supplies last.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The imaging companyâs newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.
CPhI Japan – organised by Informa Markets – announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and safety of our community, the event will be postponed until April 14-16, 2021. The event organiser’s move to the new dates will provide more time for the market to. The post CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched appeared first on Pharma Mirror Magazine.
HR organizations rely on access to employee data to address regulatory requirements, support modernization projects, manage talent, and address mergers and acquisitions. However, the typical HR department has more than nine systems of record and over four hundred data elements per employee, causing many organizations to struggle to find the information they need to meet their HR business objectives.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
SGX-listed Singapore eDevelopment Limited’s (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. (“Impact”), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. Impact Biomedical’s transition to the Quantum research program comes on the heels of the completion of the research and development stage of its existing biodefense.
Older adults who receive a flu shot have a 28 percent reduced risk of suffering a heart attack and are 17 percent less likely to develop Alzheimer’s disease, according to two new studies out of Texas. The research provides an even more compelling reason to get vaccinated for those on the fence about the shot’s effectiveness at preventing the seasonal flu.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content